W304409

L-(+)-Tartaric acid

≥99.7%, FCC, FG

• Sinónimos: (2R,3R)-(+)-Tartaric acid, L-Threaric acid
• Fórmula lineal: HO₂CCH(OH)CH(OH)CO₂H
• Número de CAS: 87-69-4
• Peso molecular: 150.09
• Número de FEMA: 3044
• Beilstein: 1725147
• Número CE: 201-766-0
• nº del Consejo Europeo: 18
• Número MDL: MFCD00064207
• Código UNSPSC: 12164502
• ID de la sustancia en PubChem: 24901442
• Número Flavis: 8.018
• NACRES: NA.21

Propiedades

• origen biológico: synthetic
• grado: FG; Halal
• Agency: meets purity specifications of JECFA
• cumplimiento norm.: EU Regulation 1334/2008 & 178/2002; FCC; FDA 21 CFR 163.110; FDA 21 CFR 163.111; FDA 21 CFR 163.112; FDA 21 CFR 184.1099
• densidad de vapor: 5.18 (vs air)
• Análisis: ≥99.7%
• formulario: crystalline powder
• actividad óptica: [α]20/D +12.5°, c = 20 in H₂O
• temp. de autoignición: 797 °F
• mp: 170-172 °C (lit.)
• solubilidad: water: soluble 150 g/L at 25 °C
• trazas de catión: As: ≤3 ppm; Cd: ≤1 ppm; Hg: ≤1 ppm; heavy metals (as Pb): ≤2 ppm
• aplicaciones: flavors and fragrances
• Documentación: see Safety & Documentation for available documents
• alérgeno alimentario: no known allergens
• Organoléptico: odorless
• cadena SMILES: O[C@H]([C@@H](O)C(O)=O)C(O)=O
• InChI: 1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1
• Clave InChI: FEWJPZIEWOKRBE-JCYAYHJZSA-N

Descripción

Descripción general

L-(+)-Tartaric acid is an organic acid commonly used as an acidulant, flavor enhancer, firming agent and humectant.

Aplicación

• Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms and tablets made from paper.: This study leverages terahertz spectroscopy to assess the crystallinity of L-(+)-tartaric acid in innovative pharmaceutical applications, enhancing non-destructive testing methods for quality control (Ornik et al., 2020 May). Link to the article.


• Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.: Research shows the use of L-(+)-tartaric acid in cocrystal formulations with itraconazole to improve its pulmonary absorption, demonstrating a significant advancement in drug delivery technologies (Karashima et al., 2017 Jun). Link to the article.


• Physicochemical Evaluation and Developability Assessment of Co-amorphouses of Low Soluble Drugs and Comparison to the Co-crystals.: This article discusses the role of L-(+)-tartaric acid in enhancing the solubility and bioavailability of pharmaceuticals through co-amorphous systems, offering a critical insight into drug formulation strategies (Yamamoto et al., 2016 Dec). Link to the article.


• Functionalized polycarbonate derived from tartaric acid: enzymatic ring-opening polymerization of a seven-membered cyclic carbonate.: This research explores the synthesis of biodegradable polymers from L-(+)-tartaric acid, emphasizing its utility in developing environmentally friendly materials (Wu et al., 2008 Oct). Link to the article.

Información de seguridad

• Pictogramas: GHS05
• Palabra de señalización: Danger
• Frases de peligro: H318
• Consejos de prudencia: P280 - P305 + P351 + P338
• Clasificaciones de peligro: Eye Dam. 1
• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 1
• Punto de inflamabilidad (°F): 302.0 °F - closed cup
• Punto de inflamabilidad (°C): 150 °C - closed cup
• Equipo de protección personal: dust mask type N95 (US), Eyeshields, Gloves